secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-06-25T20:01:31+00:00
Accession:  0001213900-26-072033
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical CEO Brent Lucas receives updated compensation: $420k salary, $105k bonus target, 1M options, 1M RSUs
--------------------------------------------------------------------------------

- CEO Brent Lucas base salary raised to $420,000 per year, cash bonus targeted at $105,000 based on 2026-2027 strategic goals.
- Committee approved issuance of 1,000,000 stock options at $0.634 per share, vesting over four years.
- 1,000,000 restricted stock units granted, vesting upon FDA approval of Acclaim cochlear implant (performance period through June 18, 2030).
- RSU award is subject to Envoy Medical's 2023 Equity Incentive Plan and includes mandatory sale to cover withholding taxes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026072033/0001213900-26-072033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026072033/ea0295990-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-072033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer